Link to this page
Physician Data Query
Last uploaded:
August 27, 2019
Jump to:
| Id | http://purl.bioontology.org/ontology/PDQ/CDR0000656988
http://purl.bioontology.org/ontology/PDQ/CDR0000656988
|
|---|---|
| Preferred Name | ADE regimen |
| Definitions |
A regimen consisting of cytarabine (Ara-C), daunorubicin and etoposide, that is used as an induction treatment for pediatric acute myeloid leukemia (AML) ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C9579" NCI Thesaurus)
|
| Synonyms |
ARA-C/DNR/VP-16
cytarabine-daunorubicin-etoposide regimen
AraC-daunorubicin-etoposide regimen
ADE
cytarabine/daunorubicin/etoposide
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A regimen consisting of cytarabine (Ara-C), daunorubicin and etoposide, that is used as an induction treatment for pediatric acute myeloid leukemia (AML) ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C9579" NCI Thesaurus) |
|---|---|
| altLabel |
ARA-C/DNR/VP-16
cytarabine-daunorubicin-etoposide regimen
AraC-daunorubicin-etoposide regimen
ADE
cytarabine/daunorubicin/etoposide
|
| prefLabel | ADE regimen
|
| notation | CDR0000656988
|
| ORIG STY | Drug/agent
|
| Date last modified | 2016-04-22
|
| Semantic type UMLS property | |
| NCI ID | C9579
|
| type | |
| tui | T061
|
| DATE FIRST PUBLISHED | 2009-10-12
|
| cui | C0057163
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |